Phage therapy reduces bacterial burden and inflammation in a neutropenic murine sepsis model caused by hyperinvasive carbapenem-resistant Klebsiella pneumoniae
Klebsiella pneumoniae is an emerging opportunistic pathogen associated with severe clinical outcomes, and carbapenem-resistant K. pneumoniae (CRKP) has become a critical threat requiring alternative therapeutic strategies. Phage therapy has recently gained attention as a promising alternative to combat antimicrobial resistance. However, its efficacy alone and in combination with antibiotics in immunocompromised hosts remains understudied. Here, we established a cyclophosphamide-induced neutropenic murine sepsis model due to a hyperinvasive CRKP strain carrying multiple virulence factors. In vitro , ceftazidime-avibactam (CAZ-AVI) at 8/4 μg/mL was required to suppress growth of this strain for 48 h, and this concentration was slightly reduced to 4/4 μg/mL when combined with a cocktail of three taxonomically distinct phages (P24, P39, and P49). In vivo , a single dose of the phage cocktail (9 × 10 8 plaque-forming units/mouse), administered intravenously or intraperitoneally following bacterial challenge, achieved 2.5–5.1 log 10 reductions of bacterial burdens across multiple tissues and organs. Correspondingly, serum tumor necrosis factor-α, interleukin-6, and interleukin-1β levels decreased significantly, and histopathological analysis revealed markedly mitigated inflammatory infiltration and tissue damage in the lung and liver. Both administration routes achieved comparable outcomes. Furthermore, in a delayed-treatment survival experiment, treatment with the phage cocktail combined with CAZ-AVI, initiated 2 h after lethal challenge, resulted in an 83.3% survival over the 28-day observation period. In contrast, all untreated mice succumbed within 2 days, and phage cocktail alone resulted in only 8.3% survival. Collectively, these findings provide in vivo evidence supporting the combination of phage cocktail and CAZ-AVI against CRKP infection in immunocompromised hosts. IMPORTANCE Carbapenem-resistant K. pneumoniae (CRKP) has emerged as a critical threat to global public health, causing life-threatening infections, disproportionately affecting immunocompromised patients who often fail to respond to conventional antibiotic therapy and experience high mortality rates. However, the efficacy of phage therapy in this vulnerable population and the comparative performance of different administration routes remain largely unexplored. Here, we established a cyclophosphamide-induced neutropenic murine sepsis model to evaluate the therapeutic potential of a phage cocktail against CRKP. We demonstrate that both intravenous and intraperitoneal phage administration achieve substantial bacterial load reduction and significant attenuation of systemic inflammation, revealing that phage therapy retains a robust positive response even in the absence of a fully functional host immune system. These findings underscore the clinical translational potential of phage as a viable alternative to antibiotics for combating CRKP infections in immunocompromised patients and provide critical evidence supporting intravenous phage delivery as a feasible administration route.
Authors
- Zhiyong Zong (ORCID: https://orcid.org/0000-0002-7675-260X)
- Meilin Li
- Yan Feng (ORCID: https://orcid.org/0009-0007-8187-5106)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- State Key Laboratory of Biotherapy (CN)
Publication Details
- Journal
- Microbiology Spectrum
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1128/spectrum.02332-26
- Primary Topic
- Bacteriophages and microbial interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China